The enhanced permeability and retention effect of nanoparticles has become the gold standard principle for cancer drug delivery systems, holding the promise of safe, simple and effective therapy. Nevertheless, due to its poor clinical translation, many recent papers describe the limitations of this EPR effect. Hence, efforts should be provided to overcome these barriers allowing the enhancement of nanomedicines on the market. This communication reviews three main strategies to enhance the EPR effect: (i) the normalization of the tumor vasculature; (ii) the possibility to include collagenase or hyaluronidase into the tumor microenvironment to simultaneously improve the transport and reduce the interstitial fluid pressure and (iii) the increa...
The current enhanced permeability and retention (EPR)-based approved nanomedicines have had little i...
Nanomedicines are being tasked with boosting the efficacy of existing immunotherapies. Understanding...
Pancreatic cancer (PCa) is one of the leading causes of morbidity worldwide, and theranostic approac...
Following its discovery more than 30 years ago, the enhanced permeability and retention (EPR) effect...
The tumor accumulation of nanomedicines relies on the enhanced permeability and retention (EPR) effe...
The performance of nanomedicine formulations depends on the Enhanced Permeability and Retention (EPR...
Theranostic nanoparticles recently received great interest for uniting unique functions to amplify t...
Nanomedicines including liposomes, micelles, and nanoparticles based on the enhanced permeability an...
Tumor targeting by nanomedicine-based therapeutics has emerged as a promising approach to overcome t...
Exploring the enhanced permeability and retention (EPR) effect through therapeutic nanoparticles has...
Abstract Development of nanoparticle-based drug delivery systems has been attempted for the treatmen...
Chemotherapy for human solid tumors in clinical practice is far from satisfactory. Despite the disco...
The enhanced permeability and retention (EPR) effect in cancer treatment is one of the key mechanism...
The current enhanced permeability and retention (EPR)-based approved nanomedicines have had little i...
Nanomedicines are being tasked with boosting the efficacy of existing immunotherapies. Understanding...
Pancreatic cancer (PCa) is one of the leading causes of morbidity worldwide, and theranostic approac...
Following its discovery more than 30 years ago, the enhanced permeability and retention (EPR) effect...
The tumor accumulation of nanomedicines relies on the enhanced permeability and retention (EPR) effe...
The performance of nanomedicine formulations depends on the Enhanced Permeability and Retention (EPR...
Theranostic nanoparticles recently received great interest for uniting unique functions to amplify t...
Nanomedicines including liposomes, micelles, and nanoparticles based on the enhanced permeability an...
Tumor targeting by nanomedicine-based therapeutics has emerged as a promising approach to overcome t...
Exploring the enhanced permeability and retention (EPR) effect through therapeutic nanoparticles has...
Abstract Development of nanoparticle-based drug delivery systems has been attempted for the treatmen...
Chemotherapy for human solid tumors in clinical practice is far from satisfactory. Despite the disco...
The enhanced permeability and retention (EPR) effect in cancer treatment is one of the key mechanism...
The current enhanced permeability and retention (EPR)-based approved nanomedicines have had little i...
Nanomedicines are being tasked with boosting the efficacy of existing immunotherapies. Understanding...
Pancreatic cancer (PCa) is one of the leading causes of morbidity worldwide, and theranostic approac...